Trial Profile
Local immunotherapy by the synergism of monobenzone and imiquimod cream (MI) for cutanous metastases in stage III-IV melanoma patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2011
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Monobenzone (Primary)
- Indications Cancer metastases; Malignant melanoma
- Focus Therapeutic Use
- 25 Jun 2011 New trial record